Management of Serotonin Syndrome

Diagnosis and Recognition

Serotonin syndrome is characterized by a clinical triad of mental status changes, autonomic hyperactivity, and neuromuscular abnormalities, according to the American Academy of Pediatrics 1
Diagnosis is best made using the Hunter Criteria, which require the presence of a serotonergic agent plus one of the following: spontaneous clonus, inducible clonus with agitation or diaphoresis, ocular clonus with agitation or diaphoresis, tremor and hyperreflexia, or hypertonia with temperature above 38°C and ocular or inducible clonus 2, 3
Clonus and hyperreflexia are considered highly diagnostic for serotonin syndrome when occurring with serotonergic drug use, as stated by the American Academy of Pediatrics 1, 4
Symptoms typically develop within minutes to hours (usually 6-24 hours) after starting or increasing the dose of a serotonergic medication, according to the American College of Medical Toxicology 4

Discontinue all serotonergic agents, as recommended by the American College of Medical Toxicology 2, 4
Provide IV fluids for dehydration and autonomic instability, according to the American College of Emergency Physicians 2
Administer benzodiazepines as first-line treatment for agitation, neuromuscular symptoms, and tremor, as stated by the American College of Medical Toxicology 2, 4
Implement external cooling measures for hyperthermia (cooling blankets), as recommended by the American Academy of Pediatrics 1, 2
Avoid physical restraints as they may exacerbate isometric contractions, worsening hyperthermia and lactic acidosis, according to the American Academy of Pediatrics 1, 2

Serotonin syndrome can be confused with other conditions such as neuroleptic malignant syndrome, malignant hyperthermia, anticholinergic syndrome, and withdrawal syndromes, as stated by the American College of Medical Toxicology 1, 2
The mortality rate for serotonin syndrome is approximately 11%, emphasizing the importance of prompt recognition and treatment, according to the American College of Medical Toxicology 2, 3
Approximately one-quarter of patients require intubation, mechanical ventilation, and ICU admission, as reported by the American College of Medical Toxicology 2
Antipyretics are typically ineffective for hyperthermia in serotonin syndrome as the fever results from muscular hyperactivity rather than hypothalamic thermoregulation changes, according to the American College of Medical Toxicology 4
Cyproheptadine may cause sedation and hypotension as side effects, as stated by the American College of Medical Toxicology 4

Watch for complications including rhabdomyolysis, metabolic acidosis, elevated serum aminotransferase, renal failure, seizures, and disseminated intravascular coagulopathy, as recommended by the American College of Medical Toxicology 4
Severe cases may require prolonged ICU care and monitoring, according to the American College of Medical Toxicology 2

The American Academy of Child and Adolescent Psychiatry recommends immediate cessation of all serotonergic medications combined with aggressive supportive care as the cornerstone of treatment, with a focus on discontinuing offending agents and providing supportive care 5

Hospitalization is required for moderate to severe cases, with treatment escalating based on severity, including hospital-based management with continuous cardiac monitoring 5, 6, 7

The use of cyproheptadine, a serotonin antagonist at 5-HT2A receptors, is recommended, with dosing guidelines including 12 mg orally initially, then 2 mg every 2 hours until symptom improvement, and maintenance of 8 mg every 6 hours after initial control 5